On genomics, NGS, and doing much more good than bad, with Markus Vossman

Illumina innovative sequencing and array technologies are fuelling groundbreaking advancements in life sciences research, translational and consumer genomics, and molecular diagnostics.

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Markus Vossman, Germany general manager at Illumina, about innovative genomic applications and projects in the region.

Vossman discusses the genomics landscape, as well as next-generation sequencing (or NGS), and the Model Project, a large-scale national pilot project aiming to evaluate the utility of genomic sequencing for patients with advanced cancer and rare diseases.

You can listen to episode 235 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.